Surgical Science Sweden AB (publ)
SUSRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $884,087 | $882,853 | $802,540 | $366,778 |
| % Growth | 0.1% | 10% | 118.8% | – |
| Cost of Goods Sold | $286,189 | $269,974 | $271,023 | $100,836 |
| Gross Profit | $597,898 | $612,879 | $531,517 | $265,942 |
| % Margin | 67.6% | 69.4% | 66.2% | 72.5% |
| R&D Expenses | $196,110 | $181,645 | $172,786 | $65,707 |
| G&A Expenses | $77,119 | $72,509 | $63,652 | $66,043 |
| SG&A Expenses | $252,379 | $240,023 | $201,875 | $145,960 |
| Sales & Mktg Exp. | $175,260 | $167,514 | $138,223 | $79,917 |
| Other Operating Expenses | $5,089 | $2,059 | -$5,681 | -$2,248 |
| Operating Expenses | $453,578 | $423,727 | $368,980 | $209,419 |
| Operating Income | $144,320 | $189,152 | $162,537 | $88,751 |
| % Margin | 16.3% | 21.4% | 20.3% | 24.2% |
| Other Income/Exp. Net | $13,773 | $79,112 | $45,636 | -$22,947 |
| Pre-Tax Income | $158,093 | $268,264 | $208,173 | $65,804 |
| Tax Expense | $26,446 | $34,292 | $20,199 | -$20,444 |
| Net Income | $131,646 | $233,972 | $187,974 | $86,248 |
| % Margin | 14.9% | 26.5% | 23.4% | 23.5% |
| EPS | 2.58 | 4.59 | 3.7 | 2.03 |
| % Growth | -43.8% | 24.1% | 82.3% | – |
| EPS Diluted | 2.58 | 4.59 | 3.69 | 2.02 |
| Weighted Avg Shares Out | 51,026 | 50,974 | 50,801 | 42,488 |
| Weighted Avg Shares Out Dil | 51,026 | 50,941 | 50,914 | 42,669 |
| Supplemental Information | – | – | – | – |
| Interest Income | $13,773 | $79,112 | $65,120 | $32,228 |
| Interest Expense | $0 | $15,042 | $1,305 | $22,947 |
| Depreciation & Amortization | $25,329 | $23,000 | $43,638 | $26,295 |
| EBITDA | $169,651 | $214,287 | $271,295 | $115,046 |
| % Margin | 19.2% | 24.3% | 33.8% | 31.4% |